Mississippi Governor Vetoes Medical Cannabis Expansion Bills
Mississippi medical cannabis program challenges continue as the governor vetoes bills expanding access. This policy decision impacts patient care and clinical decision-making. Meanwhile, psychedelic research initiatives advance, creating a complex…
Ibogaine Research Pilot Program One Step Closer to Reality After Committee Vote – Denver7
The ibogaine research pilot program in Colorado marks a significant step toward clinical investigation of this psychedelic. This program focuses on addiction treatment research while addressing cardiac safety concerns. The pilot aims to establish…
Cannabis and Psychedelics Among U.S. Young Adults: Use, Messaging Exposure, Perceptions, and Legalization Support.
This study analyzed cannabis psychedelic use young adults in the U.S. focusing on use patterns, messaging exposure, and legalization support. It provides key insights into perceptions among 18-34 year olds. The findings help inform clinical understanding…
The combination of exercise and psychedelics for the treatment of major depressive disorder.
Upwards of 50% of people do not respond to the primary treatment modalities for major depressive disorder (MDD), which has led to increased attention and use of combination exercise psychedelics depression approaches. This commentary explores the…
A New Take on the Antidepressants vs Psychedelics Efficacy Debate – Drug Science
This article explores psychedelic therapies for depression, focusing on their efficacy compared to traditional antidepressants. It highlights the clinical complexity in comparing these treatments for patients with treatment-resistant depression.…
Utah Governor Signs Bill To Support Clinical Trials On Psychedelics For Veterans’ Mental Health
Utah's new legislation supports clinical trials veterans mental health by creating a formal pathway for psychedelic research. This approach prioritizes evidence-based evaluation for PTSD and depression in veterans. The bill emphasizes controlled clinical…
Cannabinoid Study Depression Anxiety PTSD Insights
This article highlights a cannabinoid study depression anxiety PTSD research relevant to cannabis clinical practice. It compares cannabinoids with other treatments for mood disorders. The findings provide insights into therapeutic potential and safety…
